ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

A+| A| A-


on the basis of reduction of the ceiling prices of bulk drugs, the National Pharmaceutical Pricing Authority (NPPA) in its first significant action has certainly scored brownie points; but just how much of an impact will this have on the overall and sharply rising public/private expenditure on medicines and therefore on health care?

Dear Reader,

To continue reading, become a subscriber.

Explore our attractive subscription offers.

Click here

Back to Top